MAPT and Alzheimer disease: Okadaic acid (OA) is a selective inhibitor of protein serine/threonine phosphatases 1, 2A and 2B, causing tau hyperphosphorylation and neurofibromin accumulation, which is commonly used to mimic the AD symptoms of NFT injury.